Is it safe to use kratom with Zoloft (sertraline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kratom and Zoloft (Sertraline): Safety Concerns

Do not combine kratom with Zoloft (sertraline) due to significant risk of serotonin syndrome and dangerous drug interactions. The Society for Perioperative Assessment and Quality Improvement explicitly recommends discontinuing kratom due to potential for serious adverse effects, and kratom has documented serotonergic activity that can precipitate life-threatening serotonin syndrome when combined with SSRIs like sertraline 1, 2.

Primary Safety Concerns

Serotonin Syndrome Risk

  • Kratom affects serotonergic pathways in addition to opioid receptors, creating a dangerous interaction when combined with sertraline, which inhibits serotonin reuptake 3.
  • A documented case report describes a patient who developed severe serotonin syndrome (temperature 106°F, hyperreflexia, clonus, confusion) while taking kratom with multiple serotonergic medications, requiring cyproheptadine treatment and intensive care 2.
  • Serotonin syndrome typically manifests within 24-48 hours of combining serotonergic agents, presenting with mental status changes, neuromuscular hyperactivity (tremors, clonus, hyperreflexia), and autonomic instability (hyperthermia, diaphoresis, tachycardia) 4, 2.

Pharmacokinetic Drug Interactions

  • Kratom inhibits CYP2D6, CYP3A4, CYP2C9, and CYP1A2 enzymes, which can increase sertraline plasma concentrations and toxicity risk 2, 5.
  • Sertraline undergoes extensive first-pass metabolism through cytochrome P450 pathways, and kratom's enzyme inhibition can lead to unpredictable drug accumulation 6.
  • Kratom also inhibits P-glycoprotein efflux transporters, potentially further increasing systemic exposure to sertraline 5.

Clinical Guideline Recommendations

  • The Society for Perioperative Assessment and Quality Improvement (SPAQI) explicitly states that kratom use is not recommended due to potential for serious adverse effects 1.
  • Kratom has opioid agonist properties and requires tapering if discontinued due to withdrawal risk, particularly in patients taking more than 5-15 grams daily 1.
  • The FDA has issued warnings against kratom use due to safety concerns 1.

Additional Risks of Kratom

  • Kratom has been associated with liver toxicity, seizures, and death, particularly in the context of polysubstance use 3.
  • Kratom can cause physical and psychological dependence with classic opioid withdrawal symptoms upon cessation 3.
  • Deaths involving kratom are frequently observed in combination with other drugs, suggesting dangerous polyintoxication potential 5.

Critical Monitoring If Patient Is Already Using Both

If a patient presents already taking both kratom and sertraline:

  • Immediately assess for serotonin syndrome symptoms: confusion, agitation, tremors, hyperreflexia, clonus, hyperthermia, diaphoresis, mydriasis 2.
  • Check vital signs including temperature, heart rate, and blood pressure 2.
  • Consider laboratory evaluation including creatine phosphokinase (CPK) and lactate if serotonin syndrome is suspected 2.
  • Discontinue kratom immediately with appropriate tapering protocol if the patient has been using high doses (>5-15 grams daily) to prevent withdrawal 1.

Common Pitfalls to Avoid

  • Do not assume kratom is safe because it is marketed as a "natural" or "herbal" supplement—it has potent pharmacological effects on multiple neurotransmitter systems 3.
  • Do not underestimate the risk of serotonin syndrome with this combination, as kratom's serotonergic effects are well-documented 2, 3.
  • Do not continue kratom while on sertraline even at low doses, as the enzyme inhibition effects can cause unpredictable drug accumulation 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Drug Interactions and Safe Prescribing Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Translating Kratom-Drug Interactions: From Bedside to Bench and Back.

Drug metabolism and disposition: the biological fate of chemicals, 2023

Research

Clinical pharmacokinetics of sertraline.

Clinical pharmacokinetics, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.